"Erlanger is a nationally-acclaimed, multi-hospital health system anchored by a leading academic medical center. Each year, more than 600,000 people are treated by the team of healthcare professionals. Erlanger Health System serves East Tennessee, North Georgia, Northeast Alabama, and Western North Carolina"

During the past decade, Erlanger Medical Center conducted 52 clinical trials. In the 10-year time frame, 52 clinical trials started and 46 clinical trials were completed, i.e. on average, 88.5% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 20 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Erlanger Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 23 trials, followed by "University of Tennessee" with 12 trials sponsored, "Boston Scientific Corporation" with 9 trials sponsored, "Abbott Medical Devices" with 8 trials sponsored and "Vanderbilt-Ingram Cancer Center" with 8 trials sponsored. Other sponsors include 61 different institutions and companies that sponsored additional 57 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Erlanger Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 19 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator, "North Central Cancer Treatment Group" with 4 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 39 different institutions and companies that were collaborators in the rest 44 trials.

According to Clinical.Site data, the most researched conditions in "Erlanger Medical Center" are "Breast Cancer" (8 trials), "Atrial Fibrillation" (5 trials), "Ischemic Stroke" (5 trials), "Lung Cancer" (5 trials) and "Recurrent Melanoma" (5 trials). Many other conditions were trialed in "Erlanger Medical Center" in a lesser frequency.

Most popular intervention types in "Erlanger Medical Center" are "Drug" (70 trials), "Other" (36 trials), "Device" (34 trials), "Biological" (21 trials) and "Procedure" (13 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (19 trials), "Placebo" (14 trials), "Bevacizumab" (10 trials), "Quality-of-Life Assessment" (10 trials) and "Paclitaxel" (6 trials). Other intervention names were less common.

The vast majority of trials in "Erlanger Medical Center" are 103 trials for "All" genders, 20 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Erlanger Medical Center". undefined are not yet recruiting, 11 are recruiting, 31 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 53 completed trials in Erlanger Medical Center, undefined suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in Erlanger Medical Center, 3 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 50 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 33 trials that are defined as “Not Applicable".

Erlanger Medical Center has several departments that took part in Clinical trials: "Chattanooga's Program in Women's Oncology" - 33 trials, "Erlanger Oncology & Hematology - Univ. of TN" - 9 trials, "Erlanger Cancer Center" - 4 trials, "Chattanooga Bariatrics" - 2 trials, "Erlanger Hospital Pharmacy" - 2 trials